A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS)

A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS)

Efficacy of mesenchymal stem cells (MSCs) for treatment of acute respiratory distress syndrome (ARDS) suggests bioactive bone marrow MSC extracellular vesicles (BM-MSC EVs) may be effective. A patient with severe COVID-19 associated ARDS who was presumed to expire was treated with a BM-MSC EV prepar...

Full description

Bibliographic Details
Main Authors: Erik Osborn, John T. Ransom, Anastasiya Shulman, Vikram Sengupta, Mohammed Choudhry, Ali Hafiz, Jacob Gooden, Amy L. Lightner
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Mesenchymal stem cell
MSC
Extracellular vesicle
EV
ARDS
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007124001102

Internet

http://www.sciencedirect.com/science/article/pii/S2213007124001102

Similar Items